Jim was recently interviewed about environmental concerns in bio/pharmaceutical outsourcing. He spoke about the implications that drug manufacturing has on the environment and how process chemists work to refine or… Read the interview.
Overall flow of money into early stage bio/pharma companies and acquisition activity in the industry… Jim Miller’s perspective
This extensive study estimates the demand for contract injectable manufacturing through 2019. Learn more about the latest trends for outsourcing of commercially approved injectable products.
Proprietary Global Sourcing Intelligence in an Instant Decision-makers at CMOs, CDMOs and Bio/Pharma companies rely on PharmSource, to understand industry trends and company capabilities. Quickly get hard-to-find information and benefit from PharmSource’s trademark quantitative approach to analysis. Learn more
Jim was recently interviewed about PharmSource’s CapEx Trend Report. He spoke about the implications that emerged from PharmSource’s research on nearly 250 public companies, including on CMO capacity expansion… Read the interview.